...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Reply from Sarah
Reply New Message
Back To Forum List View
Icon president Reply from Sarah
3
BearDownAZ
Dec 11, 2015 02:21PM
Re: Reply from Sarah
2
KayakerBC
Dec 11, 2015 02:31PM
Re: Reply from Sarah
5
Toinv
Dec 11, 2015 06:20PM
Re: Reply from Sarah

PVLee
Dec 11, 2015 07:16PM
Re: Reply from Sarah
1
KayakerBC
Dec 11, 2015 08:18PM
Re: Reply from Sarah
4
Toinv
Dec 12, 2015 08:56AM
Icon president Re: Reply from Sarah
3
BearDownAZ
Dec 12, 2015 09:15AM
Re: Reply from Sarah
5
PVLee
Dec 12, 2015 09:58AM
Re: Reply from Sarah
4
Toinv
Dec 12, 2015 10:07AM
Re: Reply from Sarah
2
KayakerBC
Dec 12, 2015 11:30AM

Kayaker...you won't be getting any Newco shares with this proposal. Nothing changes for us except the Company name. It is not a split but only a re-org.

3 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply